Xspray Pharma AB (publ) (STO:XSPRAY)

Sweden flag Sweden · Delayed Price · Currency is SEK
26.95
+0.05 (0.19%)
Apr 28, 2026, 5:29 PM CET
-23.00%
Market Cap 1.12B
Revenue (ttm) 2.47M
Net Income (ttm) -171.44M
Shares Out 41.74M
EPS (ttm) -4.46
PE Ratio n/a
Forward PE 2.24
Dividend n/a
Ex-Dividend Date n/a
Volume 32,548
Average Volume 71,261
Open 27.00
Previous Close 26.90
Day's Range 26.75 - 27.95
52-Week Range 23.10 - 64.10
Beta -0.03
RSI 47.67
Earnings Date May 6, 2026

About Xspray Pharma AB

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the treatment of chronic myeloid leukemia (CML)and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib for the treatment of CML; XS008, an axitinib for the treatment of kidney cancer; and XS025, a amorphous non-crystalline cabozantinib for the treatment of renal cell carcinoma and other cancers. It has partn... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 26
Stock Exchange Nasdaq Stockholm
Ticker Symbol XSPRAY
Full Company Profile

Financial Performance

Financial Statements